Ironwood Pharmaceuticals (IRWD) Profit After Tax (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Profit After Tax across 17 years of filings, most recently posting $51.3 million for Q2 2026.

• In Q2 2026, Profit After Tax rose 117.34% year-over-year to $51.3 million; the TTM figure through Jun 2026 stood at $129.9 million (up 1747.03% YoY), while the FY2025 annual figure was $24.0 million, up 2629.2% from the prior year.
• Profit After Tax came in at $51.3 million for Q2 2026 at Ironwood Pharmaceuticals, up from $40.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $51.3 million in Q2 2026 to a low of -$1.1 billion in Q2 2023.
• Average Profit After Tax over 5 years is -$41.0 million, with a median of $19.5 million recorded in 2023.
• Year-over-year, Profit After Tax slumped 3038.18% in 2023 and soared 2844.07% in 2025.
• Over 5 years, Profit After Tax stood at $48.9 million in 2022, then sank by 103.57% to -$1.7 million in 2023, then soared by 229.28% to $2.3 million in 2024, then plunged by 200.89% to -$2.3 million in 2025, then soared by 2353.56% to $51.3 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were $51.3 million in Q2 2026, $40.8 million in Q1 2026, and -$2.3 million in Q4 2025.